speb/financial-data huggingface dataset:
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 1705700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 3400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 3400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Deferred Taxes Liabilities: 1500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 226500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 10000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 230300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 163300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 80000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 29700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 29700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 10700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3326000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 691100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 15200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 31600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 76300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 4188700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 5400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 230300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1070000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 112700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 15200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 5298800000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 33100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 4340700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 958100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 3593100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 731600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1479200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 659400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 176200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 2580800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 617200000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 58681000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 58681000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 351617000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 351617000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2489663000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2489663000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 60743000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 60743000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 7700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 7700000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 15200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 15200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Basic EPS: 20.07
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.20
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 51800000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 32998000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 32998000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -873300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 40095000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 40095000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 152000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 152000000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 25668000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 25668000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1167602000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1167602000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 25668000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 25668000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -41300000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -4200000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -6100000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Payable: -132400000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -22800000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -199200000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -23300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 152000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 152000000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4697443000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1960000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1960000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1059100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 275100000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 2118015000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 2118015000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 4586000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4586000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 4586000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 4586000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 60048000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 60048000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 272532000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 272532000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 10000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 10000000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Depreciation: 513000000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 513000000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 15200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 15200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 19.98
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.16
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 147800000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 4290000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 4290000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — EBIT: 956000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — EBIT: 198300000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — EBITDA: 1469000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 198300000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 28500000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -7800000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 29400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 29400000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 329500000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -58300000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 2600000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 102107000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 351617000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 351617000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 5850167000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5850167000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Gross Profit: 1521700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 342100000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 0.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Interest Expense: 7500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 5000000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 7500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5000000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Interest Income: 55894000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 55894000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -500000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 27200000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Inventory: 151857000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 151857000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4697443000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1218300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 0.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 35509000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 35509000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 35509000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 35509000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 14481000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 14481000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 317518000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 317518000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income: 147800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 147800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 147800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 147800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 147800000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 948500000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 147800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -7500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -5000000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -372200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -7500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5000000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3360504000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3360504000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -873300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4697443000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 723500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 723500000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 16244000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 16244000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1469000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 198300000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Normalized Income: 705700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 147800000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1202800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Operating Income: 862300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 165900000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 2580800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 617200000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 15200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 15200000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 34000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 34000000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 61494000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 61494000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 36198000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 36198000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -23700000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 10500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 10500000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 100.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 100.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 93700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 32400000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 446300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 125700000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 21448000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 21448000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 75791000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 75791000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 209979000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 209979000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1141934000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1141934000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Other Special Charges: 2633000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Payables: 84419000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 84419000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9945000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9945000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 33971000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 33971000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Pretax Income: 948500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 193300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Properties: 5421900000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: -3700000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -2045000000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -873300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 122457000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 122457000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1059100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 275100000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 513000000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 28199000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 36445000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 202989000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 202989000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 3862043000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3862043000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1672800000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1742000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 103849000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 15200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 15200000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Special Income Charges: -22666000.00
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 22900000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4697443000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4697443000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Tax Provision: 242800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 45500000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
ANTELOPUS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -20300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 5760285100.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 5760285100.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4697443000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 40095000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 40095000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 4697443000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4697443000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Total Expenses: 1718500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 451300000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1062842100.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1062842100.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3642270000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3642270000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 790310100.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 790310100.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 35662000.00
ANTELOPUS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1845483000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1845483000.00
ANTELOPUS.NS income_statement (annual, 2025-03-31) — Write Off: 20033000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 138400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 506300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 15200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.19
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 245200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 15200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.18
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — EBIT: 152000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — EBITDA: 152000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 261100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 152000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 112200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Operating Income: 122700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 506300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 29300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 100900000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 150000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 245200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 37800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
ANTELOPUS.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 383600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 143800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 551300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 78600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 344000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 11100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 35148810.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 3.36
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 37900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 351600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 57600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1501700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 351600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5876300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1584300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 271200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2265000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 5000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 5000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Deferred Taxes Liabilities: 12000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 644400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 9400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 35359281.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.34
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — EBIT: 159500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 159500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1828700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 280100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1800000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 348300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5876300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 11100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 32900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 32900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 14500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1800000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 4965900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5876300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 757100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 159500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 118100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Operating Income: 136300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 551300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 35162358.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 71000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 82400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 5524700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 59200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 23200000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 110100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 244400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1444100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 78600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 157700000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 271200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 35162358.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5876300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5876300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 39600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 7325200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5876300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 37900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5876300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 415000000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1448900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5060200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 804500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1620600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 163500000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 711100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 35141800.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 8.11
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 183300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 35272277.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 8.08
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — EBIT: 383400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 383400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 527800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1600000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 383400000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 285000000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 364300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 711100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 19100000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 118300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 381800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 183300000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 96800000.00
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
ANTELOPUS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 346800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 746600000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 300900000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 2788800000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1020100000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 83300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 83300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 672100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 672100000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 11400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 11400000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 35154963.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 35161588.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Basic EPS: 25.49
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 10.83
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 28500000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -2188300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 35500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 35500000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 351600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 351600000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 62300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 62300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 704900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 704900000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -176600000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -22800000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 60200000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 26800000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -320500000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -422200000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 33800000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 351600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 351600000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6554500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6554500000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 2102600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 2102600000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 929400000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 229700000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1836400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1836400000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 5300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 5300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 666600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 666600000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 16600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 16600000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Depreciation: 473200000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 473200000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 35349112.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 35357474.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 25.35
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 10.77
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — EBIT: 1201700000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — EBIT: 506800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — EBITDA: 1674900000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 506800000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 62300000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -8400000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -982300000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -37600000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 470600000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 470600000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2472700000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2472700000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Gross Profit: 1859400000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 790400000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Interest Expense: 7300000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1900000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 7300000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1900000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -100000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 37400000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Inventory: 408300000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 408300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 6554500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 6554500000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1163800000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 11400000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 11400000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 30200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 30200000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30200000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 30200000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 17500000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 17500000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 380800000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1194400000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 896100000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 380800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Interest Income: -7300000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1900000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 987100000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -7300000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1900000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 5876100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 5876100000.00
ANTELOPUS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -2188300000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 6083900000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6083900000.00
ANTELOPUS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 972100000.00
ANTELOPUS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 972100000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1674900000.00
ANTELOPUS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 506800000.00
ANTELOPUS.NS income_statement (annual, 2026-03-31) — Normalized Income: 896100000.00